Dr Lal Pathlabs Ltd Share Price Today - Dr Lal Pathlabs Ltd Stock Price Live NSE/BSE

Dr Lal Pathlabs Ltd

NSE: LALPATHLAB BSE: 539524

₹1405.80

(-0.84)%

Wed, 04 Feb 2026, 01:01 am

MTF 5xInvest in Dr Lal Pathlabs Ltd with 5x Leverage Buy with MTF

Market Cap237.95B

PE Ratio44.47

Dividend0.88

Health Services

Medical/Nursing Services

24.5K

1 Day

0 (0%)

No Result Found

Summary

Market Cap
23547.34
Net Profit
492.25
P/B
9.53
Sector P/E
54.69
P/E
42.52
EV/EBITDA
25.39
Debt/Equity (Industry)
0.19
Interest Cover (Industry)
12.58
ROCE (Industry)
18.36
RONW (Industry)
15.35
ROE
24.48
ROCE
29.23
Debt/Equity
0.10
EPS (TTM)
32.76
Dividend Yield
0.85
Book Value
142.51
Interest Cover
29.01

Analysis

all

Pros

Dividends paid are well covered by earnings (2.3x coverage).
Dividends after 3 years are expected to be well covered by earnings (3.9x coverage).
Dr. Lal PathLabs's earnings growth is expected to exceed the low risk savings rate of 7.2%.
Dr. Lal PathLabs's earnings are expected to increase by more than the low risk growth rate in 3 years time.
Dr. Lal PathLabs is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).

Cons

Dividend payments have increased, but Dr. Lal PathLabs only paid a dividend in the past 4 years.
Whilst dividend payments have been stable, Dr. Lal PathLabs has been paying a dividend for less than 10 years.
Dr. Lal PathLabs's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Dr. Lal PathLabs's dividend is below the markets top 25% of dividend payers in India (3.08%).
Cash flow for Dr. Lal PathLabs is expected to increase but not above the 50% threshold in 2 years time.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	53.22	53.22	53.79	53.91	53.91
FII	20.29	21.86	21.68	23.91	26.82
DII	19.21	18.49	17.91	16.08	13.17
Public	7.28	6.44	6.62	6.10	6.11
Government	0.01	0	0	0	0

Technical Analysis

RSI

46.32

MACD

-11.85

50 DMA

1447.86

200 DMA

1502.55

Support and Resistance

Type	R1	R2	R3	PP	S1	S2	S3
Classic	1774.50	1599.70	1504.60	1424.90	1329.80	1250.10	1075.30
Fibonacci	1599.70	1532.93	1491.67	1424.90	1358.13	1316.87	1250.10
Camarilla	1457.57	1441.55	1425.52	1424.90	1393.48	1377.45	1361.43

Pivots Level: Classic

+349.60

1774.50

+174.80

1599.70

+79.70

1504.60

1424.90

Pivot Point

LTP: 1405.80

-95.10

1329.80

-174.80

1250.10

-349.60

1075.30

Moving Average

SMAEMA

Period

Value

10-EMA
1409.04
20-EMA
1415.39
30-EMA
1425.98
50-EMA
1448.67
100-EMA
1481.27
200-EMA
1486.46

Announcement Date	Purpose	Action	Ex Date
30 Jan 2026	dividend	₹3.50 Dividend /Share	05 Feb 2026
30 Jan 2026	board-meetings	Quarterly Results
12 Dec 2025	bonus	1:1 Bonus Issue of Equity Shares	12 Dec 2025
31 Oct 2025	dividend	₹7.00 Dividend /Share	07 Nov 2025
31 Oct 2025	board-meetings	Quarterly Results, Half Yearly Results, Interim Dividend, Bonus Issue
31 Jul 2025	dividend	₹6.00 Dividend /Share	06 Aug 2025
25 Apr 2025	dividend	₹6.00 Dividend /Share	06 Jun 2025
25 Apr 2025	agm
06 Feb 2025	egm
30 Jan 2025	dividend	₹6.00 Dividend /Share	05 Feb 2025

Dr Lal Pathlabs Ltd

Narayana Hrudayalaya Ltd

Max Healthcare Institute Ltd

Apollo Hospitals Enterprise Ltd

Global Health Ltd

Fortis Healthcare Ltd

About Dr Lal Pathlabs Ltd

Dr. Lal PathLabs is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations.

Industry

Healthcare

Founded

1995

Headquarters

CEO

Arvind Lal

Employees

Contact

Website

http://www.lalpathlabs.com

cs@lalpathlabs.com

Phone

91-011-3024 4149

Location

E-2 Block Sector 18, Rohini, New Delhi, New Delhi, 110085

Year	History
2017	Dr Lal PathLabs is Amalgameted with Ria and Pathology Private Limited
2018	Amalgamation of Shree Computerised Pathology Laboratory, Modern Diagnostics & Modern Lab
2021	Dr Lal PathLabs Launches Bangalore Reference Laboratory.
2023	NCLT has given approval for Amalgamation between Dr. Lal PathLabs Limited and APL Institute of Clinical Laboratory & Research Private Limited.
2024	NCLT, Allahabad Bench sanctioned the Scheme of Amalgamation between two Subsidiary Companies of Dr. Lal PathLabs Limited.

Client Name	Order Side	QTY	Avg Price	Date
MULTI-MANAGER ICVC	Sell	434943	2997.11	06 Jan 2025

dr. lal pathlabs limited News

Dr Lal PathLabs Q3 Net Profit Drops 6.4% YoY

Dr Lal PathLabs reported consolidated net profit of ₹905 million in Q3, down from ₹967 million in the same quarter last year, reflecting a year-on-year decline of 6.4%.

30 Jan 2026

co actions results

Dr. Lal PathLabs Board to Meet Jan 30 for Q3 Results

Dr. Lal PathLabs has scheduled a board meeting on January 30, 2026, to consider Q3FY26 financial results and potential 3rd interim dividend for FY2025-26.

23 Jan 2026

co actions results

Dr. Lal PathLabs Launches SOVAAKA Wellness Centre

Dr. Lal PathLabs unveils SOVAAKA, a next-generation diagnostic experience centre in Gurugram, offering personalized wellness programs with advanced diagnostics, AI-supported imaging, and genetic testing.

06 Jan 2026

stocks

Dr. Lal PathLabs Board Meet Set for Jan 30, 2026

Dr. Lal PathLabs announces board meeting on January 30, 2026, to approve Q3FY26 unaudited financial results. Trading window closes from January 1 to February 1, 2026.

29 Dec 2025

co actions results

Dr. Lal PathLabs amends trust deed for RSU Plan 2025

Dr. Lal PathLabs Limited executed Fifth Supplementary Trust Deed on December 9, 2025, amending Employee Welfare Trust to incorporate new Restricted Stock Unit Plan 2025 under SEBI regulations.

15 Dec 2025

co actions results

Showing 1–5 of 46

Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800